L-Arginine treatment attenuates postharvest decay and maintains quality of strawberry fruit by promoting nitric oxide synthase pathway

2020 ◽  
Vol 168 ◽  
pp. 111253
Author(s):  
Pan Shu ◽  
Dedong Min ◽  
Wen Ai ◽  
Jiaozhuo Li ◽  
Jingxiang Zhou ◽  
...  
2015 ◽  
Vol 87 (3) ◽  
pp. 190 ◽  
Author(s):  
Yoshitomo Kobori ◽  
Keisuke Suzuki ◽  
Toshiyuki Iwahata ◽  
Takeshi Shin ◽  
Yuko Sadaoka ◽  
...  

We evaluated the effectiveness of antioxidant co-supplementation therapy using Larginine and Pycnogenol<sup>®</sup> in Japanese men with oligoasthenozoospermia and mild erectile dysfunction (ED). A total of forty-seven adult males with oligoasthenoteratozoospermia syndrome (OAT) were eligible for enrollment. The effectiveness of supplementation with a combination of L-arginine 690 mg and French maritime pine bark extract (Pycnogenol<sup>®</sup>) 60mg for OAT and ED was investigated. The sperm concentration was enhanced significantly after treatment 2 and 4 months (11.79 ± 9.86 to 21.22 ± 28.17 and 20.15 ± 23.99 × 106/ml). Significant improvements in the International Index of Erectile Function (IIEF) were observed in the total score of IIEF (57.69 ± 11.04 to 59.43 ± 12.57) and domain of Orgasmic Function (9.01 ± 1.92 to 9.34 ± 1.66) after 4 months of treatment. L-arginine acts to increase the production of nitric oxide and Pycnogenol<sup>®</sup> activates the endothelial nitric oxide synthase and it is a potent antioxidant and inhibitor of inducible nitric oxide synthase. This study suggests that the combination of Pycnogenol<sup>®</sup> and L-arginine (Edicare<sup>®</sup>) is helpful for infertile men to ameliorate simultaneously quality of sperms as well as erectile functions.


2013 ◽  
Vol 14 (2) ◽  
pp. 177-186 ◽  
Author(s):  
Alberto Montesanto ◽  
Paolina Crocco ◽  
Federica Tallaro ◽  
Francesca Pisani ◽  
Bruno Mazzei ◽  
...  

Author(s):  
Chi-Ming Wei ◽  
Margarita Bracamonte ◽  
Shi-Wen Jiang ◽  
Richard C. Daly ◽  
Christopher G.A. McGregor ◽  
...  

Nitric oxide (NO) is a potent endothelium-derived relaxing factor which also may modulate cardiomyocyte inotropism and growth via increasing cGMP. While endothelial nitric oxide synthase (eNOS) isoforms have been detected in non-human mammalian tissues, expression and localization of eNOS in the normal and failing human myocardium are poorly defined. Therefore, the present study was designed to investigate eNOS in human cardiac tissues in the presence and absence of congestive heart failure (CHF).Normal and failing atrial tissue were obtained from six cardiac donors and six end-stage heart failure patients undergoing primary cardiac transplantation. ENOS protein expression and localization was investigated utilizing Western blot analysis and immunohistochemical staining with the polyclonal rabbit antibody to eNOS (Transduction Laboratories, Lexington, Kentucky).


2001 ◽  
Vol 120 (5) ◽  
pp. A684-A684
Author(s):  
I DANIELS ◽  
I MURRAY ◽  
W GODDARD ◽  
R LONG

2001 ◽  
Vol 120 (5) ◽  
pp. A176-A176
Author(s):  
P KOPPITZ ◽  
M STORR ◽  
D SAUR ◽  
M KURJAK ◽  
H ALLESCHER

Sign in / Sign up

Export Citation Format

Share Document